Tibsovo is a prescription drug that’s used to treat certain types of cancers in some adults. The drug comes as a tablet that you swallow. It’s usually taken once per day. Tibsovo is used in ...

Tibsovo is already approved in the US as a monotherapy for people aged 75 or over with IDH1-mutated AML who aren't able to receive chemotherapy, and also as a second-line therapy for patients who ...

Servier is on course to get a return on its $1.8 billion takeover of Agios Pharma's oncology business after getting a key FDA approval for Tibsovo, the main asset in the deal. The US regulator has ...